Hefei Lifeon Pharmaceutical (003020.SZ): The application for the listing of cefditoren pivoxil raw materials has been approved.

20/12/2024

GMT Eight

Hefei Lifeon Pharmaceutical (003020.SZ) announced that the company has recently received the approval notice for the market application of gemifloxacin from the National Medical Products Administration. Gemifloxacin is a fourth-generation fluoroquinolone broad-spectrum antibacterial drug developed by the Japanese company Kyorin. It is mainly used for various infectious diseases caused by sensitive pathogens.

Chengdu Leejun Industrial (002651.SZ) signed a cooperation agreement with Dazhong Mining to upgrade high-pressure roller mills and existing roller mills.

Hefei Lifeon Pharmaceuticals (003020.SZ): Application for registration and approval of marketing authorization for Telmisartan Potassium Tablets (40mg and 80mg) has been accepted.

Contact: contact@gmteight.com

Hefei Lifeon Pharmaceutical (003020.SZ): The application for the listing of cefditoren pivoxil raw materials has been approved.

RECOMMEND

US Stock Market Move | Illegal opening of deposit accounts prosecuted Walmart Inc. (WMT.US) fell more than 3%

The US consumer confidence index saw a significant drop in December, indicating weakening economic expectations and signaling a possible recession.

US Stock Market Move | Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rebounds over 4% after dropping 17% the previous trading day.